Phase II study of docetaxel in combination with epirubicin and protracted venous infusion 5-fluorouracil (ETF) in patients with recurrent or metastatic breast cancer. A Yorkshire b...

Por Humphreys, A C, Dent, J, Rodwell, S, Crawford, S M, Joffe, J K, Bradley, C, Dodwell, D, Perren, T J
Publicado em 2004

A phase II study of recombinant interferon-beta (r-hIFN-beta 1a) in combination with 5-fluorouracil (5-FU) in the treatment of patients with advanced colorectal carcinoma.

Por Joffe, J. K., Perren, T. J., Bradley, C., Primrose, J., Hallam, S., Ward, U., Illingworth, J. M., Selby, P. J.
Publicado em 1997

Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial

Por Waters, J S, Norman, A, Cunningham, D, Scarffe, J H, Webb, A, Harper, P, Joffe, J K, Mackean, M, Mansi, J, Leahy, M, Hill, A, Oates, J, Rao, S, Nicolson, M, Hickish, T
Publicado em 1999

Treatment of metastatic renal cell carcinoma with subcutaneous interleukin 2: evidence for non-renal clearance of cytokines.

Por Banks, R. E., Forbes, M. A., Hallam, S., Jenkins, A., Wadhwa, M., Dilger, P., Meager, A., Thorpe, R., Bowmer, C. J., Joffe, J. K., Patel, P., Johnson, P. W., Selby, P. J.
Publicado em 1997